General Information of the Compound
Compound ID
CP0391397
Compound Name
4-[(3-Bromophenyl)amino]pyrazino[2,3-g]quinazoline
    Show/Hide
Structure
Formula
C16H10BrN5
Molecular Weight
352.195
Canonical SMILES
Brc1cccc(Nc2ncnc3cc4nccnc4cc23)c1
    Show/Hide
InChI
InChI=1S/C16H10BrN5/c17-10-2-1-3-11(6-10)22-16-12-7-14-15(19-5-4-18-14)8-13(12)20-9-21-16/h1-9H,(H,20,21,22)
    Show/Hide
InChIKey
ZZAZKOOJVIBTOP-UHFFFAOYSA-N
Physicochemical Property
logP
4.0791
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
63.59
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5328246
SID: 15597995
ChEMBL ID
CHEMBL173498
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS